{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-245701","form_type":"8-K","ticker":"INTI","cik":"0001042418","company_name":"Inhibitor Therapeutics, Inc.","filed_at":"2022-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.758527+00:00","generated_at":"2026-06-23T09:17:44.676855+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Inhibitor Therapeutics settles derivative/class actions; Mayne to pay $14.25M cash and surrender equity","bullets":["Mayne to pay $14.25M cash and surrender all its equity (205M+ common shares, convertible preferred, warrants); Mayne debt of $3M canceled.","Individual defendants Brendan Magrab, Stefan Cross, R. Dana Ono, et al. to retire from board/management; their options/warrants canceled.","Third Amended Supply and License Agreement with Mayne canceled; Company retains royalty on future US SUBA-Itraconazole BCCNS sales.","Company's hedgehog-related patents to Mayne become non-exclusive; Mayne's itraconazole formulation patents licensed to Company are terminated.","Settlement hearing set for November 10, 2022 in Delaware Chancery Court; plaintiffs may seek up to $2M in fees from the cash consideration."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-245701","json":"https://secwatch.observer/filing/0001193125-22-245701.json","markdown":"https://secwatch.observer/filing/0001193125-22-245701.md","text":"https://secwatch.observer/filing/0001193125-22-245701.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1042418/000119312522245701/0001193125-22-245701-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1042418/000119312522245701/d120799d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T09:17:44.676855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}